EUVIMEDOpdag EUVIMED
Crossref

Longitudinal Serotonergic and Dopaminergic Binding: Impact on Parkinson's Disease Progression and Levodopa Dyskinesia

Eun Hye Jeong, Jae Yong Lee, Yoo Sung Song iD

Journal of Neuroimaging · 2025

DOI: 10.1111/jon.70014 ↗

At a glance

Journal article in Journal of Neuroimaging, 2025. Written by Eun Hye Jeong and 2 co-authors. Institution: Department of Neurology, Bundang Jesaeng General Hospital, Seongnam-si, Republic of Korea. Major MEDLINE topics: Parkinson Disease, Levodopa, Dyskinesia, Drug-Induced, Serotonin. Cited 1 times so far (Crossref); 18 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose We investigated the relationship between serotonergic and dopaminergic specific binding transporter ratios (SBRs) over 4 years in Parkinson's disease (PD) patients. We assessed serotonergic innervation's potential compensatory role for dopaminergic denervation, association with PD symptoms, and involvement in the development of levodopa‐induced dyskinesia (LID).

Methods

SBRs of the midbrain and striatum were evaluated from [I‐123] N ‐ω‐fluoropropyl‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)nortropane SPECT images at baseline and after 4 years. Correlations between SBRs and PD symptoms were analyzed, alongside interval changes.

Results

Study included 177 PD patients (110 males, 67 females; mean age 61.0 ± 9.0 years). Significant worsening was observed in Hoehn and Yahr staging and Movement Disorder Society‐Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) Part II and III scores over 4 years ( p < 0.05, p < 0.001, and p < 0.001, respectively). SBRs of the caudate, putamen, and midbrain declined significantly ( p < 0.001). Midbrain and striatal SBRs correlated significantly at both baseline and 4‐year follow‐up ( p < 0.0001). Striatal SBRs correlated significantly with MDS‐UPDRS II and III scores at both time points, while midbrain SBRs correlated with changes in MDS‐UPDRS III scores over the 4 years ( p < 0.01). Putamen and midbrain SBRs at 4 years were significantly lower in patients who developed LID compared to those who did not ( p < 0.05).

Conclusion

The study demonstrates correlations between midbrain and putamen SBRs and MDS‐UPDRS scores over 4 years in PD patients. Midbrain serotonin dysfunction may contribute to the development of LID.

Subjects

MeSH terms (MEDLINE)

Parkinson DiseaseLevodopaDyskinesia, Drug-InducedSerotoninHumansMaleFemaleMiddle AgedTomography, Emission-Computed, Single-PhotonDisease ProgressionLongitudinal StudiesAntiparkinson AgentsAgedMesencephalon

Author keywords

dopaminelevodopa‐induced dyskinesiamidbrainserotoninspecific binding transporter ratio

Substances

LevodopaAntiparkinson AgentsSerotonin

Authors and institutions

  • Department of Neurology, Bundang Jesaeng General Hospital, Seongnam-si, Republic of Korea.
  • Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
  • College of Medicine, Seoul National University, Seoul, Republic of Korea.

ORCID profiles: Yoo Sung Song

Cite

APA

Jeong, E. H., Lee, J. Y., & Song, Y. S. (2025). Longitudinal Serotonergic and Dopaminergic Binding: Impact on Parkinson's Disease Progression and Levodopa Dyskinesia. Journal of Neuroimaging. https://doi.org/10.1111/jon.70014

Vancouver

Jeong EH, Lee JY, Song YS. Longitudinal Serotonergic and Dopaminergic Binding: Impact on Parkinson's Disease Progression and Levodopa Dyskinesia. Journal of Neuroimaging. 2025. doi:10.1111/jon.70014

BibTeX
@article{Jeong2025,
  author = {Jeong, Eun Hye and Lee, Jae Yong and Song, Yoo Sung},
  title = {Longitudinal Serotonergic and Dopaminergic Binding: Impact on Parkinson's Disease Progression and Levodopa Dyskinesia},
  journal = {Journal of Neuroimaging},
  year = {2025},
  doi = {10.1111/jon.70014}
}
Start for free →